Aspira Women's Health Inc.
AWHL· OTC
Released May 11, 2022, during market hours
10-Q filed May 11, 2022, 41 days after period end · 0000926617-22-000032
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $1.89M | $1.50M | $1.22M | $803.00K |
| Net Income | -$9.27M | -$5.92M | -$3.71M | -$3.72M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$1.24 |
| -$0.05 |
| -$0.04 |
| -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.